{"ticker": {"uuid": "42cecc3b-3e97-4cbb-ab42-ecb7fbdd2410", "symbol": "STTK", "name": "Shattuck Labs\u00a0Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Shattuck Labs, Inc. (STTK) Discusses Phase I Results for DR3 Blocking Antibody SL-325 and Pipeline Update - Slideshow (NASDAQ:STTK) 2026-07-08", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOemVlYktkNldNUUNCaDdGajRBNjdxRm44R28zM1pGT1pIWU5QMkZsekRxUjVld3Fzc3R4Y1RYcTBRM1pyMDFxZHQ2RWFVZ2VGajdfaURONDZJZDRmai1KYi1xWW41UFBUSGx0TGRWWHd5WjgxUlk3cnlxNHdZUk1VSkZhVW9VX2NtckREaVhVRFQyY3NKazB5NnhCWVZwaE56T2F6djR5UXZJT0FNekY3dXBMaTIybnhfWmVXOERRNmhPT2JQcDludVdmaw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-08T23:32:50+00:00", "published_display": "08 Jul 2026 23:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs CTO Abhinav Shukla sells $2,874 in company stock", "summary": "Shattuck Labs CTO Abhinav Shukla sold 410 shares of company stock worth $2,874 on July 2, 2026, as part of a Rule 10b5-1 trading plan to cover option exercise costs. On the same day and again on July 6, 2026, Mr. Shukla acquired a total of 12,563 shares through stock option exerc", "url": "https://www.investing.com/news/insider-trading-news/shattuck-labs-cto-abhinav-shukla-sells-2874-in-company-stock-93CH-4780528", "source_name": "Investing.com", "published_at": "2026-07-08T21:39:24", "published_display": "08 Jul 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs CTO Abhinav Shukla sells $2,874 in company stock By Investing.com", "summary": "Shattuck Labs CTO Abhinav Shukla sold 410 shares of company stock for $2,874 at a weighted average price of $7.01, pursuant to a Rule 10b5-1 trading plan. This sale occurred while the stock was trading near its 52-week high after an 840% gain. Concurrently, Shukla acquired 12,563", "url": "https://m.za.investing.com/news/stock-market-news/shattuck-labs-cto-abhinav-shukla-sells-2874-in-company-stock-93CH-4359549?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-07-08T00:10:21", "published_display": "08 Jul 2026 00:10", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Shattuck Labs Inc For: 7 July By Investing.com", "summary": "Investing.com reported the filing of a Form 4 for Shattuck Labs Inc. on July 7. The brief announcement provides no specific details from the filing, only referencing the company's stock symbol STTK.", "url": "https://ng.investing.com/news/stock-market-news/form-4-shattuck-labsinc-for-7-july-93CH-2590088", "source_name": "Investing.com Nigeria", "published_at": "2026-07-07T23:10:57", "published_display": "07 Jul 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs (STTK) CTO exercises options and makes small 10b5-1 sale", "summary": "Shattuck Labs' Chief Technical Officer, Abhinav A. Shukla, exercised options to acquire 12,563 shares of common stock at $3.57 per share. To cover the exercise costs and tax withholding, he sold 410 shares of common stock at a weighted average price of $7.01 under a pre-arranged ", "url": "https://www.stocktitan.net/sec-filings/STTK/form-4-shattuck-labs-inc-insider-trading-activity-db984de13f67.html", "source_name": "Stock Titan", "published_at": "2026-07-07T23:10:21", "published_display": "07 Jul 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs outlines its oncology platform as investors assess long-term prospects", "summary": "Shattuck Labs, a clinical-stage biotechnology company, is focused on developing novel immunotherapies for cancer and autoimmune diseases using its proprietary fusion protein technology. The company pursues a platform strategy designed to modulate immune pathways in the tumor micr", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/shattuck-labs-outlines-its-oncology-platform-as-investors-assess-long-term/69714641", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T13:10:26", "published_display": "07 Jul 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STTK - Shattuck Labs Inc Options", "summary": "This page provides a detailed financial overview of Shattuck Labs Inc (STTK), including its last close price, market capitalization, income, sales, and various financial ratios. It also presents key performance indicators such as EPS, sales growth, insider and institutional owner", "url": "https://finviz.com/stock?t=STTK&ta=1&p=d&ty=oc&r=m3", "source_name": "Finviz", "published_at": "2026-07-06T14:41:12", "published_display": "06 Jul 2026 14:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs focuses on immunotherapy pipeline as investors watch clinical milestones", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOMC1DSXd4OVJRdmRIQ3ZKLUdvSnFoR3JkMzNxRzhwemxqU05HcFBYa2dXOWw3SGJualF2bXc1NS1NNklpZHFIaWxsWnRwczBTZFNLdmpyTnRFZy1jVjM5cDBsZHBPWjJVMXNGSTBqSFpWU2JfNzlvbk1zYVFtak1xWVlhcHpJX01Ddkh6WEtCUGh2elZiY3AxRWhIY05VbTBTSkxDN19RcHREaHlEVmlTSXE1N0tYUnhVVjhxa25kal81REE?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T14:50:38+00:00", "published_display": "03 Jul 2026 14:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs cmo Pandite sells $210,300 in company stock", "summary": "Shattuck Labs' Chief Medical Officer, Pandite Arundathy N., sold 30,000 shares of the company's common stock for a total of $210,300 on June 30, 2026. This transaction was conducted under a Rule 10b5-1 trading plan, and Ms. Pandite now directly holds 136,219 shares. The sale occu", "url": "https://www.investing.com/news/insider-trading-news/shattuck-labs-cmo-pandite-sells-210300-in-company-stock-93CH-4774849", "source_name": "Investing.com", "published_at": "2026-07-03T08:09:13", "published_display": "03 Jul 2026 08:09", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Arundathy Pandite Sells 30,000 Shares of Shattuck Labs Inc (STTK)", "summary": "Arundathy Pandite, Chief Medical Officer at Shattuck Labs Inc (STTK), sold 30,000 shares of the company on June 30, 2026, reducing her holdings to 136,219 shares. Over the past year, Pandite has sold a total of 60,000 shares, with no purchases. The stock, trading at $7.01, is con", "url": "https://www.gurufocus.com/news/8944017/insider-sell-arundathy-pandite-sells-30000-shares-of-shattuck-labs-inc-sttk?mobile=true", "source_name": "GuruFocus", "published_at": "2026-07-03T04:10:59", "published_display": "03 Jul 2026 04:10", "sentiment": "negative", "sentiment_pct": 31, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abhinav Shukla, Shattuck Labs CTO, sells $166,131 in stock", "summary": "Abhinav Shukla, CTO of Shattuck Labs (NASDAQ: STTK), sold $166,131 worth of company stock across two transactions on June 30 and July 1, 2026, after exercising options. These sales were part of a Rule 10b5-1 trading plan to cover exercise prices and taxes. Despite a 746% stock in", "url": "https://www.investing.com/news/insider-trading-news/abhinav-shukla-shattuck-labs-cto-sells-166131-in-stock-93CH-4774858", "source_name": "Investing.com", "published_at": "2026-07-03T01:10:59", "published_display": "03 Jul 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs (NASDAQ: STTK) CTO option exercises and 23,465-share sale disclosed", "summary": "Shattuck Labs CTO Abhinav A. Shukla reported exercising stock options for 23,465 shares at $3.57 each and simultaneously selling the same number of shares on the open market at weighted average prices of approximately $7.08 and $7.07 per share. These transactions, conducted under", "url": "https://www.stocktitan.net/sec-filings/STTK/form-4-shattuck-labs-inc-insider-trading-activity-025f73dfedcd.html", "source_name": "Stock Titan", "published_at": "2026-07-03T00:10:59", "published_display": "03 Jul 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs (STTK) CMO sells 30,000 shares under 10b5-1 plan", "summary": "Shattuck Labs' Chief Medical Officer, Arundathy N. Pandite, sold 30,000 shares of common stock at a weighted average price of $7.01 per share. This transaction occurred on June 30, 2026, under a pre-arranged Rule 10b5-1 trading plan adopted on February 2, 2026. Following the sale", "url": "https://www.stocktitan.net/sec-filings/STTK/form-4-shattuck-labs-inc-insider-trading-activity-2eac1ee03f1f.html", "source_name": "Stock Titan", "published_at": "2026-07-03T00:10:59", "published_display": "03 Jul 2026 00:10", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "410-share sale reported by STTK insider (NASDAQ: STTK) via option exercise", "summary": "An insider of Shattuck Labs, Inc. (NASDAQ: STTK) has reported a proposed sale of 410 shares of Common Stock through a stock option exercise, to be sold for cash on July 2, 2026, with Fidelity Brokerage Services LLC listed as the broker. The SEC filing (Form 144) also details prio", "url": "https://www.stocktitan.net/sec-filings/STTK/144-shattuck-labs-inc-sec-filing-b78b4fbc9996.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:10:59", "published_display": "02 Jul 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Shattuck Labs For: 1 July By Investing.com", "summary": "This article reports on a Form 144 filing by Shattuck Labs (STTK) for July 1. Form 144 filings indicate an affiliate's intent to sell restricted securities. The article provides the date of the filing and mentions a stock performance of +8.29% for STTK, as well as current market ", "url": "https://ng.investing.com/news/stock-market-news/form-144-shattuck-labs-for-1-july-93CH-2583444", "source_name": "Investing.com Nigeria", "published_at": "2026-07-02T07:39:46", "published_display": "02 Jul 2026 07:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abhinav A. Shukla (STTK) files to sell 100 common shares via Form 144", "summary": "Abhinav A. Shukla has filed a Form 144 notice to sell 100 common shares of Shattuck Labs, Inc. (STTK), acquired through a stock option exercise. The filing, dated July 1, 2026, also details previous sales in May and June 2026 totaling 25,397 shares for combined proceeds of over $", "url": "https://www.stocktitan.net/sec-filings/STTK/144-shattuck-labs-inc-sec-filing-9e55387f6605.html", "source_name": "Stock Titan", "published_at": "2026-07-01T20:39:46", "published_display": "01 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Shattuck Labs For: 30 June By Investing.com", "summary": "This article from Investing.com is a brief report stating that Shattuck Labs (STTK) filed a Form 144 for the period ending June 30. The article indicates a slight increase in the company's stock price by 1.31% at the time of publication and is part of a series of financial news u", "url": "https://ca.investing.com/news/stock-market-news/form-144-shattuck-labs-for-30-june-93CH-4714641", "source_name": "Investing.com Canada", "published_at": "2026-06-30T20:10:15", "published_display": "30 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STTK (NASDAQ) files Rule 144 notice for stock-option sale on 06/30/2026", "summary": "Shattuck Labs, Inc. (STTK) has filed a Rule 144 notice indicating an intended sale of Common stock related to a Stock Option Exercise with a transaction date of June 30, 2026. The filing specifies Fidelity Brokerage Services LLC as the broker involved and notes cash as the consid", "url": "https://www.stocktitan.net/sec-filings/STTK/144-shattuck-labs-inc-sec-filing-5e3f1c818813.html", "source_name": "Stock Titan", "published_at": "2026-06-30T20:10:15", "published_display": "30 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs, Inc.(NasdaqGS: STTK) added to Russell 2000 Index", "summary": "Shattuck Labs, Inc. (NasdaqGS: STTK), a biotechnology company focused on treatments for inflammatory and immune-mediated diseases, has been added to the Russell 2000 Index. This inclusion means the company's stock will now be part of several Russell indices, including the Russell", "url": "https://www.marketscreener.com/news/shattuck-labs-inc-nasdaqgs-sttk-added-to-russell-2000-index-ce7f5fdfda8cfe20", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T19:10:20", "published_display": "29 Jun 2026 19:10", "sentiment": "positive", "sentiment_pct": 68, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs, Inc.(NasdaqGS:STTK) added to Russell Small Cap Comp Growth Benchmark", "summary": "Shattuck Labs, Inc. (NasdaqGS:STTK) has been added to the Russell Small Cap Comp Growth Benchmark, alongside several other Russell indices including the Russell 2500 Growth, Russell 2000, and Russell Microcap Growth benchmarks. This inclusion highlights the company's growing pres", "url": "https://www.marketscreener.com/news/shattuck-labs-inc-nasdaqgs-sttk-added-to-russell-small-cap-comp-growth-benchmark-ce7f5fdfdc88ff2d", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T17:12:00", "published_display": "29 Jun 2026 17:12", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Shattuck Labs, Inc. \u2013 NASDAQ:STTK", "summary": "This article provides financial information for Shattuck Labs, Inc. (NASDAQ: STTK). It lists the forward price-to-sales ratio and notes that the market is currently closed with no trades. The content primarily shows navigation elements and links related to financial data and anal", "url": "https://www.tradingview.com/symbols/NASDAQ-STTK/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T18:10:05", "published_display": "26 Jun 2026 18:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Shattuck Labs, Inc. \u2013 NASDAQ:STTK", "summary": "This article provides the enterprise value to EBIT forward for Shattuck Labs, Inc. (NASDAQ:STTK) as displayed on TradingView. It indicates that the market for STTK was closed at the time of viewing and presents various navigation options related to financial data, news, and commu", "url": "https://www.tradingview.com/symbols/NASDAQ-STTK/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T11:09:11", "published_display": "26 Jun 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Shattuck Labs, Inc. \u2013 NASDAQ:STTK", "summary": "This article provides the \"Price to earnings forward\" value for Shattuck Labs, Inc. (NASDAQ: STTK) on TradingView. It indicates that the market is closed, and no trades have occurred for the company. The content focuses on financial data provided by various sources like ICE Data ", "url": "https://www.tradingview.com/symbols/NASDAQ-STTK/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T00:41:12", "published_display": "26 Jun 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs, Inc. Actuals & Estimates (NASDAQ:STTK)", "summary": "This article provides an overview of Shattuck Labs, Inc. (NASDAQ:STTK) stock, including its current price, historical performance, analyst forecasts, and financial data. It highlights the stock's recent price increase, its market capitalization, and upcoming earnings report. The ", "url": "https://www.tradingview.com/symbols/NASDAQ-STTK/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T19:41:12", "published_display": "25 Jun 2026 19:41", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Citi Upgrades Shattuck Labs(STTK.US) to Buy Rating, Maintains Target Price $7", "summary": "Citi has upgraded Shattuck Labs (STTK.US) to a Buy rating. The firm has also chosen to maintain its target price for the company at $7.", "url": "https://www.moomoo.com/news/post/71089357/citi-upgrades-shattuck-labs-sttkus-to-buy-rating-maintains-target", "source_name": "Moomoo", "published_at": "2026-06-20T14:40:11", "published_display": "20 Jun 2026 14:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs drops 6%, prices $75M share raise at $4 per share", "summary": "Shattuck Labs (STTK) saw its shares drop 6% after announcing the pricing of its previously announced upsized public offering. The company will sell 18,750,000 shares of its common stock at a price of $4.00 per share, aiming to raise $75 million. The offering is expected to close ", "url": "https://www.msn.com/en-us/money/topstocks/shattuck-labs-drops-6-prices-75m-share-raise-at-4-per-share/ar-AA25h2ry?ocid=finance-verthp-feeds&apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-06-20T13:40:41", "published_display": "20 Jun 2026 13:40", "sentiment": "negative", "sentiment_pct": 31, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orbimed Advisors LLC Increases Stake in Shattuck Labs Inc", "summary": "Orbimed Advisors LLC has increased its stake in Shattuck Labs Inc (STTK) by acquiring an additional 2,715,000 shares, bringing its total holdings to over 9 million shares. This strategic move, executed at $4.18 per share, signifies Orbimed's confidence in the biotechnology compan", "url": "https://www.gurufocus.com/news/8924435/orbimed-advisors-llc-increases-stake-in-shattuck-labs-inc", "source_name": "GuruFocus", "published_at": "2026-06-20T01:10:59", "published_display": "20 Jun 2026 01:10", "sentiment": "positive", "sentiment_pct": 64, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs Inc (STTK) Institutional Confidence", "summary": "The article provides an overview of Shattuck Labs Inc (STTK)'s institutional confidence score, shareholding proportion, and key institutional shareholders. The company has an institutional shareholding score of 5.00, ranking 133 out of 388 in its industry, with 65.78% of shares h", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-sttk/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T10:39:56", "published_display": "18 Jun 2026 10:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs Inc (STTK) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Shattuck Labs Inc (STTK), detailing its current price momentum score, identified support and resistance levels, and a comprehensive breakdown of various technical indicators and moving averages. While the stock is trading between resi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-sttk/technical", "source_name": "TradingKey", "published_at": "2026-06-18T09:38:43", "published_display": "18 Jun 2026 09:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs Inc (STTK) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Shattuck Labs Inc (STTK), identifying its major individual and institutional investors. It provides a breakdown of shareholder types, institutional holdings over several quarters, and a list of key shareholders with their respecti", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-sttk/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T08:38:43", "published_display": "18 Jun 2026 08:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs (NASDAQ: STTK) launches stock and pre-funded warrant offering at $4.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNdGpMdGhBa0FjaHVLYTZnOGxxenZZdm1tdUZVM29BR05Qb01HLUhkMU5kMkUxWnUzLXMtdGdZMFpacUN6WkdtbVFyNWVwcGVDd3kzTVJlYmNJY201NjVEb1hHMFNvWlR2RnVFNDN2OXlOUDJQcmR4UG1vbXRnNVRoZjZZR1F6UWpMd1ByQUdHdkNIeXhkVmJyNWs0Ylc1WU85U2U1eEo4RjNrUQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs Prices $75 Million Public Offering", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/shattuck-labs-prices-75-million-101325766.html", "source_name": "MT Newswires", "published_at": "2026-06-10T10:13:25+00:00", "published_display": "10 Jun 2026 10:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs prices $75M public offering at $4 per share", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxORXFjaFRQRGRaaHZpWVBnQkJpWWtaT3RnZUxZNjkwNW1mc0NvNzVlOWdHelF4bmRVYlJ5R3ZfYlJVVGwxaFZHVlN6T01SRENnanFJdmhLb2lRUFdzTEVLTjM0U1BJSGE5bjhHN1pqdFc1Sll1N0NseHpIR1haemVpN2VVR0lPTkRTWUZGRTF3WnNfVk1DVnhCbWxMVEJ4bmxUNTBMUEsxWGc1VmtJa1NCaW1R?oc=5", "source_name": "Investing.com", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/shattuck-labs-inc-announces-pricing-042100020.html", "source_name": "GlobeNewswire", "published_at": "2026-06-10T04:21:00+00:00", "published_display": "10 Jun 2026 04:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs Launches Public Offering of Common Stock", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/shattuck-labs-launches-public-offering-203609233.html", "source_name": "MT Newswires", "published_at": "2026-06-09T20:36:09+00:00", "published_display": "09 Jun 2026 20:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs, Inc. Announces Proposed Public Offering", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/shattuck-labs-inc-announces-proposed-201800425.html", "source_name": "GlobeNewswire", "published_at": "2026-06-09T20:18:00+00:00", "published_display": "09 Jun 2026 20:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs Announces Exercise of Outstanding Common Stock Warrants and Provides Financial Update", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/shattuck-labs-announces-exercise-outstanding-120000249.html", "source_name": "GlobeNewswire", "published_at": "2026-06-09T12:00:00+00:00", "published_display": "09 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Shattuck Labs stock up 14% today? By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNUldVZkowN1lIZ3hGTkJqNGhISVZwcENfWmFpRHhOSlZ1dkhGakVlNk1TTDlCSGxhcjBMQmk2WFJsbndCUHc2cTFZdkpmZ2hCQ3RYbldMNi15YkdHODMyVjBXVXVlSURkV1RDVG9rUlVUNkx0dld4eVNMZTc0Y2JYYWJmY2RaVmZjVHhvVGRjdVlPREJTQWxEaXVWNi0zMW1H?oc=5", "source_name": "Investing.com South Africa", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs, Inc. Announces Public Offering of Common Stock and Pre-Funded Warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPdTlEVEgyOUVVeHZFc0NCU0szSDI4cm1ILUY5VHpRNEtPMWJ4YUtGOEUwNVlfdjBMdFQ2RnBvUDdSYURxTGVWM2cwNTB0VjBMcC10aTI4V2dwR3VQb0FoVzJqTFBGWF9FNVVTRWYwZzNpMlljVXFCQzBmNHBXNnI3MS14WENabnZyVEdHTk9rTjJuS25weGRwUXc1Y1ZiWXEyN3draGk2eTNocGJiUGh6ZVpJVmY0YWp3dmZqOQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs Reports Good Safety Results for Phase 1 Study of Drug Candidate for Immune-Related Disease", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/shattuck-labs-reports-good-safety-110347220.html", "source_name": "MT Newswires", "published_at": "2026-06-08T11:03:47+00:00", "published_display": "08 Jun 2026 11:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs Announces Phase 1 Results for SL-325", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/shattuck-labs-announces-phase-1-100000308.html", "source_name": "GlobeNewswire", "published_at": "2026-06-08T10:00:00+00:00", "published_display": "08 Jun 2026 10:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs (STTK) Reports Positive Phase 1 Trial Outcomes for SL-325", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPZDlEUFQ4UXRFMjVSQW92X1ZOS0FvNUZBUm81WWtBSHJCUmZQZDlrODVJRE5ROExrNEVieWNlMXZ0UjZSWWlQSmxVNGk1TXp1MEtvS0xiZDAyWXN4OU1NSFJBZnN0UVZDZmZyaGlSOW9DcElZSzl2cklLMHFYaVNDOHFacVZ2b3J1bzdSRUNTLUk5SFlqaVFlMTRUeGVObUx0V3ZnaW5ZNUFEdk1lWjRlSkYzOUowcEpRUFpr?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs stock jumps 17% on Phase 1 trial results", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNWWkycEVCblExQUQ1YzVaVnB1TE9lcmNUVkdoQ0ZXM2hISDN5NGxDVkpQY3RJU05WOTFoN3o0aFI0UHduV21nUnUyQ0ViUGg0dU1ENnA3V2lrZXpzdlZrREVheG1kM2MtcUZOTG9HWXB2aVYwb1A2MVpYNlBVYkRST0tHVlN2SWkyWW5kbk1pUWpqNUYxdEt3RzJRM0lRVVZwWDN6VTRLY0ppMHdhQU5FVjBPMktUUQ?oc=5", "source_name": "Investing.com", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/shattuck-labs-host-investor-call-200500697.html", "source_name": "GlobeNewswire", "published_at": "2026-06-05T20:05:00+00:00", "published_display": "05 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Citigroup Upgrades Shattuck Labs to Buy From Neutral, Price Target is $7", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/citigroup-upgrades-shattuck-labs-buy-112053128.html", "source_name": "MT Newswires", "published_at": "2026-06-05T11:20:53+00:00", "published_display": "05 Jun 2026 11:20", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs to Present Phase 1 Clinical Data for SL-325 and Pipeline Update on June 8, 2026 | STTK Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQOWhRWlJmMGtkRlY5YUpGYUgxcGVKSkoxNVVGWmJHTFNGNERBeVZhZkRVcmpRRlZFSWM1Sm5TRzVWX0I1eElBWWQwTTVKV2hiOE9iVXhuSldVMWdMRTUyM1RDWHcwb0lBUEhhZWN2Y2QxbnlPaVROcVVxYlZZWGphQkRZaFh4VDNkeUpQQ2E0Z2pBSEdYdU9RSS1oVUMwV2NyNzZ2Z2hBWVFlejcxeEpJU1h1ZkVCN1d6UmU5Q2laVVo0eF9LaGxv?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why We're Not Too Worried About Shattuck Labs' (NASDAQ:STTK) Cash Burn Situation", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "We're Not Very Worried About Shattuck Labs' (NASDAQ:STTK) Cash Burn Rate", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxORE5qNmNUUDJnNTVqdWdYZC1KTFlyU0V6MTNtTnhYd2ZBWE90R0cwaFBTc2NEcXdaaFJKc0o0aVlaX1RBQkpoVWJFOG1PVlIxSVZYTmwtUDAwb0Vlemx3TnVRZEhDbzVMbFdXVWpieVJlSmNCdkludHpJb2tWTldabV9Ec2dTMUhCelVMQ2I0MUV2X2I4WWJqSFU2Zw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Cantor Fitzgerald Initiates Coverage of Shattuck Labs (STTK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNcF9GR0RKWWZZN2VFaXRXNGRIQ01QSmQ5MDNDYVlyN1FIUnVSeW0xbVVQZFViYjNwcE5LZU9MMkU4bE5DTXVqLWVCNk1lSXRYSXh0RER1VXJUdHo0cGt5NzhxdmNSUWp4ZlAxdkN4UnBkRUVvVlEtNXA0ZkNBaTQzX0dPQ3dpQW1DYWdsMmxFYTgxSmhsdFg1ZjY3ZmYtT2dxLWdYSnQ5V0xYUmh4NGdV?oc=5", "source_name": "Market source", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Why Shattuck Labs Stock Soared More Than 53% Higher This Week", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNdXdZYTd3TF90cGxxcW9QVlQ3TmE1RDNGdmZNUl83eHdmUFc4NXdiX1FGVVRaZ2g3TWJWN3ZYaWYxckRDYklBdXhXRnlmRWNUMTdhOUh4Slo1ckxWdWdmR1loT3BseS03MGRkYlpKS29TMFhCMDRaLVpwVUFJT3RoQ2RZRHF2V01ScnB4aWxlSUNPejdnN01tcA?oc=5", "source_name": "The Motley Fool", "published_at": "2026-03-06T08:00:00+00:00", "published_display": "06 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs Insider Buyers Net US$637k Despite 12% Stock Decline", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Shattuck Labs Stock Soared in December", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNS1ZiMkpMNkd4VTVqQk1DU29ITk05VW5HelF2clZiTHR0T0ZCcUp4cE5TX0Q3ZFBocmZnM2pRS01LV0g0QTlYQzFvQTZjVjMwVmxFem4zVjhPQ3k0V3RYeHY3dDh5dktuZUp6c3g0WFJvQUkzdkpmZlc3Z3JYSi1pc0ctM0RYMEMzem1nb21B?oc=5", "source_name": "The Motley Fool", "published_at": "2026-01-05T08:00:00+00:00", "published_display": "05 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Shattuck Labs, Inc. (STTK) Discusses Phase I Results for DR3 Blocking Antibody SL-325 and Pipeline Update - Slideshow (NASDAQ:STTK) 2026-07-08", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxOemVlYktkNldNUUNCaDdGajRBNjdxRm44R28zM1pGT1pIWU5QMkZsekRxUjVld3Fzc3R4Y1RYcTBRM1pyMDFxZHQ2RWFVZ2VGajdfaURONDZJZDRmai1KYi1xWW41UFBUSGx0TGRWWHd5WjgxUlk3cnlxNHdZUk1VSkZhVW9VX2NtckREaVhVRFQyY3NKazB5NnhCWVZwaE56T2F6djR5UXZJT0FNekY3dXBMaTIybnhfWmVXOERRNmhPT2JQcDludVdmaw?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-08T23:32:50+00:00", "published_display": "08 Jul 2026 23:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs CTO Abhinav Shukla sells $2,874 in company stock", "summary": "Shattuck Labs CTO Abhinav Shukla sold 410 shares of company stock worth $2,874 on July 2, 2026, as part of a Rule 10b5-1 trading plan to cover option exercise costs. On the same day and again on July 6, 2026, Mr. Shukla acquired a total of 12,563 shares through stock option exerc", "url": "https://www.investing.com/news/insider-trading-news/shattuck-labs-cto-abhinav-shukla-sells-2874-in-company-stock-93CH-4780528", "source_name": "Investing.com", "published_at": "2026-07-08T21:39:24", "published_display": "08 Jul 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs CTO Abhinav Shukla sells $2,874 in company stock By Investing.com", "summary": "Shattuck Labs CTO Abhinav Shukla sold 410 shares of company stock for $2,874 at a weighted average price of $7.01, pursuant to a Rule 10b5-1 trading plan. This sale occurred while the stock was trading near its 52-week high after an 840% gain. Concurrently, Shukla acquired 12,563", "url": "https://m.za.investing.com/news/stock-market-news/shattuck-labs-cto-abhinav-shukla-sells-2874-in-company-stock-93CH-4359549?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-07-08T00:10:21", "published_display": "08 Jul 2026 00:10", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Shattuck Labs Inc For: 7 July By Investing.com", "summary": "Investing.com reported the filing of a Form 4 for Shattuck Labs Inc. on July 7. The brief announcement provides no specific details from the filing, only referencing the company's stock symbol STTK.", "url": "https://ng.investing.com/news/stock-market-news/form-4-shattuck-labsinc-for-7-july-93CH-2590088", "source_name": "Investing.com Nigeria", "published_at": "2026-07-07T23:10:57", "published_display": "07 Jul 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs (STTK) CTO exercises options and makes small 10b5-1 sale", "summary": "Shattuck Labs' Chief Technical Officer, Abhinav A. Shukla, exercised options to acquire 12,563 shares of common stock at $3.57 per share. To cover the exercise costs and tax withholding, he sold 410 shares of common stock at a weighted average price of $7.01 under a pre-arranged ", "url": "https://www.stocktitan.net/sec-filings/STTK/form-4-shattuck-labs-inc-insider-trading-activity-db984de13f67.html", "source_name": "Stock Titan", "published_at": "2026-07-07T23:10:21", "published_display": "07 Jul 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs outlines its oncology platform as investors assess long-term prospects", "summary": "Shattuck Labs, a clinical-stage biotechnology company, is focused on developing novel immunotherapies for cancer and autoimmune diseases using its proprietary fusion protein technology. The company pursues a platform strategy designed to modulate immune pathways in the tumor micr", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/shattuck-labs-outlines-its-oncology-platform-as-investors-assess-long-term/69714641", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T13:10:26", "published_display": "07 Jul 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STTK - Shattuck Labs Inc Options", "summary": "This page provides a detailed financial overview of Shattuck Labs Inc (STTK), including its last close price, market capitalization, income, sales, and various financial ratios. It also presents key performance indicators such as EPS, sales growth, insider and institutional owner", "url": "https://finviz.com/stock?t=STTK&ta=1&p=d&ty=oc&r=m3", "source_name": "Finviz", "published_at": "2026-07-06T14:41:12", "published_display": "06 Jul 2026 14:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs focuses on immunotherapy pipeline as investors watch clinical milestones", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOMC1DSXd4OVJRdmRIQ3ZKLUdvSnFoR3JkMzNxRzhwemxqU05HcFBYa2dXOWw3SGJualF2bXc1NS1NNklpZHFIaWxsWnRwczBTZFNLdmpyTnRFZy1jVjM5cDBsZHBPWjJVMXNGSTBqSFpWU2JfNzlvbk1zYVFtak1xWVlhcHpJX01Ddkh6WEtCUGh2elZiY3AxRWhIY05VbTBTSkxDN19RcHREaHlEVmlTSXE1N0tYUnhVVjhxa25kal81REE?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T14:50:38+00:00", "published_display": "03 Jul 2026 14:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs cmo Pandite sells $210,300 in company stock", "summary": "Shattuck Labs' Chief Medical Officer, Pandite Arundathy N., sold 30,000 shares of the company's common stock for a total of $210,300 on June 30, 2026. This transaction was conducted under a Rule 10b5-1 trading plan, and Ms. Pandite now directly holds 136,219 shares. The sale occu", "url": "https://www.investing.com/news/insider-trading-news/shattuck-labs-cmo-pandite-sells-210300-in-company-stock-93CH-4774849", "source_name": "Investing.com", "published_at": "2026-07-03T08:09:13", "published_display": "03 Jul 2026 08:09", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Arundathy Pandite Sells 30,000 Shares of Shattuck Labs Inc (STTK)", "summary": "Arundathy Pandite, Chief Medical Officer at Shattuck Labs Inc (STTK), sold 30,000 shares of the company on June 30, 2026, reducing her holdings to 136,219 shares. Over the past year, Pandite has sold a total of 60,000 shares, with no purchases. The stock, trading at $7.01, is con", "url": "https://www.gurufocus.com/news/8944017/insider-sell-arundathy-pandite-sells-30000-shares-of-shattuck-labs-inc-sttk?mobile=true", "source_name": "GuruFocus", "published_at": "2026-07-03T04:10:59", "published_display": "03 Jul 2026 04:10", "sentiment": "negative", "sentiment_pct": 31, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abhinav Shukla, Shattuck Labs CTO, sells $166,131 in stock", "summary": "Abhinav Shukla, CTO of Shattuck Labs (NASDAQ: STTK), sold $166,131 worth of company stock across two transactions on June 30 and July 1, 2026, after exercising options. These sales were part of a Rule 10b5-1 trading plan to cover exercise prices and taxes. Despite a 746% stock in", "url": "https://www.investing.com/news/insider-trading-news/abhinav-shukla-shattuck-labs-cto-sells-166131-in-stock-93CH-4774858", "source_name": "Investing.com", "published_at": "2026-07-03T01:10:59", "published_display": "03 Jul 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs (NASDAQ: STTK) CTO option exercises and 23,465-share sale disclosed", "summary": "Shattuck Labs CTO Abhinav A. Shukla reported exercising stock options for 23,465 shares at $3.57 each and simultaneously selling the same number of shares on the open market at weighted average prices of approximately $7.08 and $7.07 per share. These transactions, conducted under", "url": "https://www.stocktitan.net/sec-filings/STTK/form-4-shattuck-labs-inc-insider-trading-activity-025f73dfedcd.html", "source_name": "Stock Titan", "published_at": "2026-07-03T00:10:59", "published_display": "03 Jul 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs (STTK) CMO sells 30,000 shares under 10b5-1 plan", "summary": "Shattuck Labs' Chief Medical Officer, Arundathy N. Pandite, sold 30,000 shares of common stock at a weighted average price of $7.01 per share. This transaction occurred on June 30, 2026, under a pre-arranged Rule 10b5-1 trading plan adopted on February 2, 2026. Following the sale", "url": "https://www.stocktitan.net/sec-filings/STTK/form-4-shattuck-labs-inc-insider-trading-activity-2eac1ee03f1f.html", "source_name": "Stock Titan", "published_at": "2026-07-03T00:10:59", "published_display": "03 Jul 2026 00:10", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "410-share sale reported by STTK insider (NASDAQ: STTK) via option exercise", "summary": "An insider of Shattuck Labs, Inc. (NASDAQ: STTK) has reported a proposed sale of 410 shares of Common Stock through a stock option exercise, to be sold for cash on July 2, 2026, with Fidelity Brokerage Services LLC listed as the broker. The SEC filing (Form 144) also details prio", "url": "https://www.stocktitan.net/sec-filings/STTK/144-shattuck-labs-inc-sec-filing-b78b4fbc9996.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:10:59", "published_display": "02 Jul 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Shattuck Labs For: 1 July By Investing.com", "summary": "This article reports on a Form 144 filing by Shattuck Labs (STTK) for July 1. Form 144 filings indicate an affiliate's intent to sell restricted securities. The article provides the date of the filing and mentions a stock performance of +8.29% for STTK, as well as current market ", "url": "https://ng.investing.com/news/stock-market-news/form-144-shattuck-labs-for-1-july-93CH-2583444", "source_name": "Investing.com Nigeria", "published_at": "2026-07-02T07:39:46", "published_display": "02 Jul 2026 07:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abhinav A. Shukla (STTK) files to sell 100 common shares via Form 144", "summary": "Abhinav A. Shukla has filed a Form 144 notice to sell 100 common shares of Shattuck Labs, Inc. (STTK), acquired through a stock option exercise. The filing, dated July 1, 2026, also details previous sales in May and June 2026 totaling 25,397 shares for combined proceeds of over $", "url": "https://www.stocktitan.net/sec-filings/STTK/144-shattuck-labs-inc-sec-filing-9e55387f6605.html", "source_name": "Stock Titan", "published_at": "2026-07-01T20:39:46", "published_display": "01 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Shattuck Labs For: 30 June By Investing.com", "summary": "This article from Investing.com is a brief report stating that Shattuck Labs (STTK) filed a Form 144 for the period ending June 30. The article indicates a slight increase in the company's stock price by 1.31% at the time of publication and is part of a series of financial news u", "url": "https://ca.investing.com/news/stock-market-news/form-144-shattuck-labs-for-30-june-93CH-4714641", "source_name": "Investing.com Canada", "published_at": "2026-06-30T20:10:15", "published_display": "30 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STTK (NASDAQ) files Rule 144 notice for stock-option sale on 06/30/2026", "summary": "Shattuck Labs, Inc. (STTK) has filed a Rule 144 notice indicating an intended sale of Common stock related to a Stock Option Exercise with a transaction date of June 30, 2026. The filing specifies Fidelity Brokerage Services LLC as the broker involved and notes cash as the consid", "url": "https://www.stocktitan.net/sec-filings/STTK/144-shattuck-labs-inc-sec-filing-5e3f1c818813.html", "source_name": "Stock Titan", "published_at": "2026-06-30T20:10:15", "published_display": "30 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs, Inc.(NasdaqGS: STTK) added to Russell 2000 Index", "summary": "Shattuck Labs, Inc. (NasdaqGS: STTK), a biotechnology company focused on treatments for inflammatory and immune-mediated diseases, has been added to the Russell 2000 Index. This inclusion means the company's stock will now be part of several Russell indices, including the Russell", "url": "https://www.marketscreener.com/news/shattuck-labs-inc-nasdaqgs-sttk-added-to-russell-2000-index-ce7f5fdfda8cfe20", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T19:10:20", "published_display": "29 Jun 2026 19:10", "sentiment": "positive", "sentiment_pct": 68, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs, Inc.(NasdaqGS:STTK) added to Russell Small Cap Comp Growth Benchmark", "summary": "Shattuck Labs, Inc. (NasdaqGS:STTK) has been added to the Russell Small Cap Comp Growth Benchmark, alongside several other Russell indices including the Russell 2500 Growth, Russell 2000, and Russell Microcap Growth benchmarks. This inclusion highlights the company's growing pres", "url": "https://www.marketscreener.com/news/shattuck-labs-inc-nasdaqgs-sttk-added-to-russell-small-cap-comp-growth-benchmark-ce7f5fdfdc88ff2d", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T17:12:00", "published_display": "29 Jun 2026 17:12", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Shattuck Labs, Inc. \u2013 NASDAQ:STTK", "summary": "This article provides financial information for Shattuck Labs, Inc. (NASDAQ: STTK). It lists the forward price-to-sales ratio and notes that the market is currently closed with no trades. The content primarily shows navigation elements and links related to financial data and anal", "url": "https://www.tradingview.com/symbols/NASDAQ-STTK/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T18:10:05", "published_display": "26 Jun 2026 18:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Shattuck Labs, Inc. \u2013 NASDAQ:STTK", "summary": "This article provides the enterprise value to EBIT forward for Shattuck Labs, Inc. (NASDAQ:STTK) as displayed on TradingView. It indicates that the market for STTK was closed at the time of viewing and presents various navigation options related to financial data, news, and commu", "url": "https://www.tradingview.com/symbols/NASDAQ-STTK/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T11:09:11", "published_display": "26 Jun 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Shattuck Labs, Inc. \u2013 NASDAQ:STTK", "summary": "This article provides the \"Price to earnings forward\" value for Shattuck Labs, Inc. (NASDAQ: STTK) on TradingView. It indicates that the market is closed, and no trades have occurred for the company. The content focuses on financial data provided by various sources like ICE Data ", "url": "https://www.tradingview.com/symbols/NASDAQ-STTK/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T00:41:12", "published_display": "26 Jun 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs, Inc. Actuals & Estimates (NASDAQ:STTK)", "summary": "This article provides an overview of Shattuck Labs, Inc. (NASDAQ:STTK) stock, including its current price, historical performance, analyst forecasts, and financial data. It highlights the stock's recent price increase, its market capitalization, and upcoming earnings report. The ", "url": "https://www.tradingview.com/symbols/NASDAQ-STTK/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T19:41:12", "published_display": "25 Jun 2026 19:41", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Citi Upgrades Shattuck Labs(STTK.US) to Buy Rating, Maintains Target Price $7", "summary": "Citi has upgraded Shattuck Labs (STTK.US) to a Buy rating. The firm has also chosen to maintain its target price for the company at $7.", "url": "https://www.moomoo.com/news/post/71089357/citi-upgrades-shattuck-labs-sttkus-to-buy-rating-maintains-target", "source_name": "Moomoo", "published_at": "2026-06-20T14:40:11", "published_display": "20 Jun 2026 14:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs drops 6%, prices $75M share raise at $4 per share", "summary": "Shattuck Labs (STTK) saw its shares drop 6% after announcing the pricing of its previously announced upsized public offering. The company will sell 18,750,000 shares of its common stock at a price of $4.00 per share, aiming to raise $75 million. The offering is expected to close ", "url": "https://www.msn.com/en-us/money/topstocks/shattuck-labs-drops-6-prices-75m-share-raise-at-4-per-share/ar-AA25h2ry?ocid=finance-verthp-feeds&apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-06-20T13:40:41", "published_display": "20 Jun 2026 13:40", "sentiment": "negative", "sentiment_pct": 31, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orbimed Advisors LLC Increases Stake in Shattuck Labs Inc", "summary": "Orbimed Advisors LLC has increased its stake in Shattuck Labs Inc (STTK) by acquiring an additional 2,715,000 shares, bringing its total holdings to over 9 million shares. This strategic move, executed at $4.18 per share, signifies Orbimed's confidence in the biotechnology compan", "url": "https://www.gurufocus.com/news/8924435/orbimed-advisors-llc-increases-stake-in-shattuck-labs-inc", "source_name": "GuruFocus", "published_at": "2026-06-20T01:10:59", "published_display": "20 Jun 2026 01:10", "sentiment": "positive", "sentiment_pct": 64, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs Inc (STTK) Institutional Confidence", "summary": "The article provides an overview of Shattuck Labs Inc (STTK)'s institutional confidence score, shareholding proportion, and key institutional shareholders. The company has an institutional shareholding score of 5.00, ranking 133 out of 388 in its industry, with 65.78% of shares h", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-sttk/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T10:39:56", "published_display": "18 Jun 2026 10:39", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs Inc (STTK) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Shattuck Labs Inc (STTK), detailing its current price momentum score, identified support and resistance levels, and a comprehensive breakdown of various technical indicators and moving averages. While the stock is trading between resi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-sttk/technical", "source_name": "TradingKey", "published_at": "2026-06-18T09:38:43", "published_display": "18 Jun 2026 09:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs Inc (STTK) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Shattuck Labs Inc (STTK), identifying its major individual and institutional investors. It provides a breakdown of shareholder types, institutional holdings over several quarters, and a list of key shareholders with their respecti", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-sttk/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T08:38:43", "published_display": "18 Jun 2026 08:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs (NASDAQ: STTK) launches stock and pre-funded warrant offering at $4.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNdGpMdGhBa0FjaHVLYTZnOGxxenZZdm1tdUZVM29BR05Qb01HLUhkMU5kMkUxWnUzLXMtdGdZMFpacUN6WkdtbVFyNWVwcGVDd3kzTVJlYmNJY201NjVEb1hHMFNvWlR2RnVFNDN2OXlOUDJQcmR4UG1vbXRnNVRoZjZZR1F6UWpMd1ByQUdHdkNIeXhkVmJyNWs0Ylc1WU85U2U1eEo4RjNrUQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs Prices $75 Million Public Offering", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/shattuck-labs-prices-75-million-101325766.html", "source_name": "MT Newswires", "published_at": "2026-06-10T10:13:25+00:00", "published_display": "10 Jun 2026 10:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs prices $75M public offering at $4 per share", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxORXFjaFRQRGRaaHZpWVBnQkJpWWtaT3RnZUxZNjkwNW1mc0NvNzVlOWdHelF4bmRVYlJ5R3ZfYlJVVGwxaFZHVlN6T01SRENnanFJdmhLb2lRUFdzTEVLTjM0U1BJSGE5bjhHN1pqdFc1Sll1N0NseHpIR1haemVpN2VVR0lPTkRTWUZGRTF3WnNfVk1DVnhCbWxMVEJ4bmxUNTBMUEsxWGc1VmtJa1NCaW1R?oc=5", "source_name": "Investing.com", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/shattuck-labs-inc-announces-pricing-042100020.html", "source_name": "GlobeNewswire", "published_at": "2026-06-10T04:21:00+00:00", "published_display": "10 Jun 2026 04:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs Launches Public Offering of Common Stock", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/shattuck-labs-launches-public-offering-203609233.html", "source_name": "MT Newswires", "published_at": "2026-06-09T20:36:09+00:00", "published_display": "09 Jun 2026 20:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs, Inc. Announces Proposed Public Offering", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/shattuck-labs-inc-announces-proposed-201800425.html", "source_name": "GlobeNewswire", "published_at": "2026-06-09T20:18:00+00:00", "published_display": "09 Jun 2026 20:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs Announces Exercise of Outstanding Common Stock Warrants and Provides Financial Update", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/shattuck-labs-announces-exercise-outstanding-120000249.html", "source_name": "GlobeNewswire", "published_at": "2026-06-09T12:00:00+00:00", "published_display": "09 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Shattuck Labs stock up 14% today? By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNUldVZkowN1lIZ3hGTkJqNGhISVZwcENfWmFpRHhOSlZ1dkhGakVlNk1TTDlCSGxhcjBMQmk2WFJsbndCUHc2cTFZdkpmZ2hCQ3RYbldMNi15YkdHODMyVjBXVXVlSURkV1RDVG9rUlVUNkx0dld4eVNMZTc0Y2JYYWJmY2RaVmZjVHhvVGRjdVlPREJTQWxEaXVWNi0zMW1H?oc=5", "source_name": "Investing.com South Africa", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs, Inc. Announces Public Offering of Common Stock and Pre-Funded Warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPdTlEVEgyOUVVeHZFc0NCU0szSDI4cm1ILUY5VHpRNEtPMWJ4YUtGOEUwNVlfdjBMdFQ2RnBvUDdSYURxTGVWM2cwNTB0VjBMcC10aTI4V2dwR3VQb0FoVzJqTFBGWF9FNVVTRWYwZzNpMlljVXFCQzBmNHBXNnI3MS14WENabnZyVEdHTk9rTjJuS25weGRwUXc1Y1ZiWXEyN3draGk2eTNocGJiUGh6ZVpJVmY0YWp3dmZqOQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs Reports Good Safety Results for Phase 1 Study of Drug Candidate for Immune-Related Disease", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/shattuck-labs-reports-good-safety-110347220.html", "source_name": "MT Newswires", "published_at": "2026-06-08T11:03:47+00:00", "published_display": "08 Jun 2026 11:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs Announces Phase 1 Results for SL-325", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/shattuck-labs-announces-phase-1-100000308.html", "source_name": "GlobeNewswire", "published_at": "2026-06-08T10:00:00+00:00", "published_display": "08 Jun 2026 10:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs (STTK) Reports Positive Phase 1 Trial Outcomes for SL-325", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPZDlEUFQ4UXRFMjVSQW92X1ZOS0FvNUZBUm81WWtBSHJCUmZQZDlrODVJRE5ROExrNEVieWNlMXZ0UjZSWWlQSmxVNGk1TXp1MEtvS0xiZDAyWXN4OU1NSFJBZnN0UVZDZmZyaGlSOW9DcElZSzl2cklLMHFYaVNDOHFacVZ2b3J1bzdSRUNTLUk5SFlqaVFlMTRUeGVObUx0V3ZnaW5ZNUFEdk1lWjRlSkYzOUowcEpRUFpr?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs stock jumps 17% on Phase 1 trial results", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNWWkycEVCblExQUQ1YzVaVnB1TE9lcmNUVkdoQ0ZXM2hISDN5NGxDVkpQY3RJU05WOTFoN3o0aFI0UHduV21nUnUyQ0ViUGg0dU1ENnA3V2lrZXpzdlZrREVheG1kM2MtcUZOTG9HWXB2aVYwb1A2MVpYNlBVYkRST0tHVlN2SWkyWW5kbk1pUWpqNUYxdEt3RzJRM0lRVVZwWDN6VTRLY0ppMHdhQU5FVjBPMktUUQ?oc=5", "source_name": "Investing.com", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/shattuck-labs-host-investor-call-200500697.html", "source_name": "GlobeNewswire", "published_at": "2026-06-05T20:05:00+00:00", "published_display": "05 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Citigroup Upgrades Shattuck Labs to Buy From Neutral, Price Target is $7", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/citigroup-upgrades-shattuck-labs-buy-112053128.html", "source_name": "MT Newswires", "published_at": "2026-06-05T11:20:53+00:00", "published_display": "05 Jun 2026 11:20", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs to Present Phase 1 Clinical Data for SL-325 and Pipeline Update on June 8, 2026 | STTK Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQOWhRWlJmMGtkRlY5YUpGYUgxcGVKSkoxNVVGWmJHTFNGNERBeVZhZkRVcmpRRlZFSWM1Sm5TRzVWX0I1eElBWWQwTTVKV2hiOE9iVXhuSldVMWdMRTUyM1RDWHcwb0lBUEhhZWN2Y2QxbnlPaVROcVVxYlZZWGphQkRZaFh4VDNkeUpQQ2E0Z2pBSEdYdU9RSS1oVUMwV2NyNzZ2Z2hBWVFlejcxeEpJU1h1ZkVCN1d6UmU5Q2laVVo0eF9LaGxv?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why We're Not Too Worried About Shattuck Labs' (NASDAQ:STTK) Cash Burn Situation", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We're Not Very Worried About Shattuck Labs' (NASDAQ:STTK) Cash Burn Rate", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxORE5qNmNUUDJnNTVqdWdYZC1KTFlyU0V6MTNtTnhYd2ZBWE90R0cwaFBTc2NEcXdaaFJKc0o0aVlaX1RBQkpoVWJFOG1PVlIxSVZYTmwtUDAwb0Vlemx3TnVRZEhDbzVMbFdXVWpieVJlSmNCdkludHpJb2tWTldabV9Ec2dTMUhCelVMQ2I0MUV2X2I4WWJqSFU2Zw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cantor Fitzgerald Initiates Coverage of Shattuck Labs (STTK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNcF9GR0RKWWZZN2VFaXRXNGRIQ01QSmQ5MDNDYVlyN1FIUnVSeW0xbVVQZFViYjNwcE5LZU9MMkU4bE5DTXVqLWVCNk1lSXRYSXh0RER1VXJUdHo0cGt5NzhxdmNSUWp4ZlAxdkN4UnBkRUVvVlEtNXA0ZkNBaTQzX0dPQ3dpQW1DYWdsMmxFYTgxSmhsdFg1ZjY3ZmYtT2dxLWdYSnQ5V0xYUmh4NGdV?oc=5", "source_name": "Market source", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Shattuck Labs Stock Soared More Than 53% Higher This Week", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNdXdZYTd3TF90cGxxcW9QVlQ3TmE1RDNGdmZNUl83eHdmUFc4NXdiX1FGVVRaZ2g3TWJWN3ZYaWYxckRDYklBdXhXRnlmRWNUMTdhOUh4Slo1ckxWdWdmR1loT3BseS03MGRkYlpKS29TMFhCMDRaLVpwVUFJT3RoQ2RZRHF2V01ScnB4aWxlSUNPejdnN01tcA?oc=5", "source_name": "The Motley Fool", "published_at": "2026-03-06T08:00:00+00:00", "published_display": "06 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shattuck Labs Insider Buyers Net US$637k Despite 12% Stock Decline", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxNQ2V4Nl9tR0xXTlNmQU5YSHpicl9XbEU4Q2Z2SVp1SzlQWUlfcnloRW5RblZ0Wi1uZHl1b3hvVTdSNXdTLVI4ZGNza1dpa2xKaUxPWUVhLXVKcGFrNEp4UzdkOEdNb0o2Q2tNTjhYMXJyemhEZzVNUUdiU1d2UkNQX0J4dzhFU09rNV95eUl5N1BCc2xUczZSanZOTWx2bExFcGxjZ2YyUi11dklFRHhjbEJjUDE3b3pzaGxfcm5zeHNrSzVQUXY2UkUycUgzeGpWN0lzVnhuWjVrbW9zbTc5NdIB5gFBVV95cUxOTFBLNGZTUFk0UHZnaFk1blJEYk03TEgxYnlKSnFCeTc4ZDZuMW0ycW9tcGZEcHdfOTg3d0R6R3E1NlgxZTN2WUNXU1VhSGZNVTZwb01WMW9RUWYxSTluMUFfQmpfMEw5ZHZNNjA2dDQxUTFLa1RjVFRzaTBIaG9aM0tyNjllVXRIUnkyem0xeFh4eTRFX1l3WUxYLTRzczcyWEVGZnhlOTRZLWk1cEE0SnJwRWYzN3RyTGRjeUpvdFhoVzlXY0VUUVM4X3VlQTN3VkdVTE5pckgycGhNeW5nT0dJa2FHdw?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Shattuck Labs Stock Soared in December", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNS1ZiMkpMNkd4VTVqQk1DU29ITk05VW5HelF2clZiTHR0T0ZCcUp4cE5TX0Q3ZFBocmZnM2pRS01LV0g0QTlYQzFvQTZjVjMwVmxFem4zVjhPQ3k0V3RYeHY3dDh5dktuZUp6c3g0WFJvQUkzdkpmZlc3Z3JYSi1pc0ctM0RYMEMzem1nb21B?oc=5", "source_name": "The Motley Fool", "published_at": "2026-01-05T08:00:00+00:00", "published_display": "05 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 100, "total_relevant": 63, "sentiment_summary": {"positive": 11, "negative": 6, "neutral": 46, "score": 52, "total": 63, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 22.55, "count": 41}, {"event": "earnings", "label": "Earnings", "weight": 7.5, "count": 15}, {"event": "liquidity", "label": "Balance sheet", "weight": 2.2, "count": 4}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 11, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 6.64, "latest_week": "2026-07-10", "one_week_move": -5.8, "four_week_move": 34.4, "twelve_week_move": -11.8, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": -0.49426, "market_dynamics_buy_signal": false, "relative_strength": 51.200618, "fair_value_gap": 77.8, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 50.7786, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-5.8% over one week, +34.4% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 7}, {"label": "Stock Titan", "count": 7}, {"label": "Investing.com", "count": 5}, {"label": "TradingView", "count": 5}, {"label": "GlobeNewswire", "count": 5}, {"label": "MT Newswires", "count": 4}, {"label": "simplywall.st", "count": 4}, {"label": "GuruFocus", "count": 3}], "tiers": [{"label": "Direct company coverage", "count": 55}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 41}, {"label": "Earnings", "count": 15}, {"label": "Balance sheet", "count": 4}, {"label": "Analyst action", "count": 2}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 classification confidence."}, {"label": "Company focus", "value": "55", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-5.8% over one week, +34.4% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Shattuck Labs, Inc. (STTK) Discusses Phase I Results for DR3 Blocking Antibody SL-325 and Pipeline Update - Slideshow (NASDAQ:STTK) 2026-07-08"}], "updated_at": "2026-07-15T23:13:29.445575+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}